|Articles|August 20, 2019

Prospectus For Establishment of a DSCSA Governance Body

Click on the link below to read the document:

Final Governance Prospectus Document_080919

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe

Related Content

Reshoring Update: BMS Commits $2.3B to Houston Campus

ByZachary Zubulake

August 10th 2026

Health Plans, PBMs Wary of TrumpRx Impact on Patients

ByAdam Colborn, JD,Stephen Appezzato

August 10th 2026

High angle satellite view of the Strait of Hormuz showing the strategic maritime chokepoint between Iran and Oman for global trade and logistics | © ink drop - stock.adobe.com (1957527497)

Escalating Iran Standoff and Red Sea Attacks Raise Freight Risk for Pharma Supply Chains

ByChristopher Cole

August 10th 2026

Closeup of a delivery man delivering medication in a white box with the word pharmacy on it to a woman. | © AntonioDiaz - stock.adobe.com

Q&A: Where Direct-to-Patient Pharma Stands Today

ByChip Parkinson,Stephen Appezzato

August 7th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | : © Tada Images - stock.adobe.com 521699065

FDA Launches Small Dispenser Assessment, Grants DSCSA Exemptions

ByStephen Appezzato

August 7th 2026

Prospectus For Establishment of a DSCSA Governance Body

Related Content

Reshoring Update: BMS Commits $2.3B to Houston Campus

Health Plans, PBMs Wary of TrumpRx Impact on Patients

Escalating Iran Standoff and Red Sea Attacks Raise Freight Risk for Pharma Supply Chains

Q&A: Where Direct-to-Patient Pharma Stands Today

FDA Launches Small Dispenser Assessment, Grants DSCSA Exemptions

Trending on Pharmaceutical Commerce

Escalating Iran Standoff and Red Sea Attacks Raise Freight Risk for Pharma Supply Chains

FDA Launches Small Dispenser Assessment, Grants DSCSA Exemptions

Reshoring Update: BMS Commits $2.3B to Houston Campus

Health Plans, PBMs Wary of TrumpRx Impact on Patients

Q&A: Where Direct-to-Patient Pharma Stands Today